2Lochnit G and Geyer R. Carbohydrate strueture analysis of batroxobin,a thrombin-like serine protease from Bothrops moojeni venom.Eur J Biochem,1995,228:805～816.
3Tomaru T,Uchida Y,Nakamura F,et al.Enhancement of arterial thrombolysis with native t-PA bypretreatment with heparin or batroxobin:Anangioscopic study.Amheart J,1989,117:275.
4Klocking HP.Release of plasm in ogenactivator by batroxobin,Haemostasis,1987,17:235.
6Resoh KL,Ernst E, Matrai A. Fribrinogen and viscosity as risk factory forsubsequent cardiovascular events in stroke survivors.Ann Intern Med, 1992,117(5):371.
8Tomaru T, Uchida Y, Nakamura F, et al.Enhancement of arterial thrombolysis with native t-PA bypretreatment with heparin or batroxobin: Anangioscopic study[J]. Am Heart J, 1989,117(2) :275.
9Klocking HP, Hoffmann A, Markwardt F.Release of plasm in ogenactivator by batroxobin[J]. Haemostasis, 1987, 17 (4):235.
10Bamford J,Sandercock P,Dennis M,et al.Classification and natural history of clinically identifiable subtypes of cerebral infarction[J].Lancet,1991,337(8756):1521-6.
